Among the several changes that occur in the aged brain is an increase in the concentration of the proinflammatory cytokine interleukin-1 that is coupled with a deterioration in cell function. This study investigated the possibility that treatment with the polyunsaturated fatty acid eicosapentaenoic acid might prevent interleukin-1-induced deterioration in neuronal function. Assessment of four markers of apoptotic cell death, cytochrome c translocation, caspase-3 activation, poly-(ADP-ribose) polymerase cleavage, and terminal dUTP nick-end staining, revealed an age-related increase in each of these measures, and the evidence presented indicates that treatment of aged rats with eicosapentaenoate reversed these changes as well as the accompanying increases in interleukin-1 concentration and p38 activation. The data are consistent with the idea that activation of p38 plays a significant role in inducing the changes described since interleukin-1-induced activation of cytochrome c translocation and caspase-3 activation in cortical tissue in vitro were reversed by the p38 inhibitor SB203580. The age-related increases in interleukin-1 concentration and p38 activation in cortex were mirrored by similar changes in hippocampus. These changes were coupled with an age-related deficit in long term potentiation in perforant path-granule cell synapses, while eicosapentaenoate treatment was associated with reversal of age-related changes in interleukin-1 and p38 and with restoration of long term potentiation.
Increased expression of the proinflammatory cytokine interleukin-1 (IL-1)1 has been linked with neurodegenerative disorders like Down's syndrome, Alzheimer's disease, and Parkinson's disease (1, 2). Consistent with the view that IL-1 plays a role in deterioration of cell function are the findings that IL-1 expression is increased, in parallel with cell damage, in experimental models of ischemia (3), excitotoxicity (4), and traumatic lesions (5). Indeed, IL-1 has been shown to trigger cell death in primary cultures of human fetal neurons (6) and inhibition of caspase-1, which leads to formation of active IL-1, and blocks lipopolysaccharide-induced changes in cell morphology, which are consistent with cell death (7).IL-1 has been shown to stimulate the mitogen-activated protein kinases p38 and c-Jun NH 2 -terminal kinase (8, 9), and activation of both c-Jun NH 2 -terminal kinase (10, 11) and p38 (10, 12-16) has been closely linked with apoptotic cell death. Significantly, an increase in p38 activity has been coupled with apoptotic changes in Alzheimer's disease (17, 18). Concomitant increases in IL-1 concentration and p38 activity have been reported in the aged rat brain (19 -21); in hippocampus these changes are correlated with compromised synaptic function and with an age-related impairment in long term potentiation (LTP) (19 -22), while consistent with the high expression of IL-1 and IL-1RI in hippocampus is the finding that the cytokine depresses LTP in dentate gyrus (8,19,20,23,24). Significantly, we have ...